183 related articles for article (PubMed ID: 34737965)
1.
Kim JH; Jeong SY; Jang HJ; Park ST; Kim HS
Front Oncol; 2021; 11():762528. PubMed ID: 34737965
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
[TBL] [Abstract][Full Text] [Related]
3. FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects.
Xu W; Li Y; Wang X; Chen B; Wang Y; Liu S; Xu J; Zhao W; Wu J
Eur J Cancer; 2010 Dec; 46(18):3332-8. PubMed ID: 20638838
[TBL] [Abstract][Full Text] [Related]
4. Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients.
Spinola M; Leoni V; Pignatiello C; Conti B; Ravagnani F; Pastorino U; Dragani TA
J Clin Oncol; 2005 Oct; 23(29):7307-11. PubMed ID: 16061909
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
Naidu R; Har YC; Taib NA
Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
[TBL] [Abstract][Full Text] [Related]
6. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
[TBL] [Abstract][Full Text] [Related]
7. Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.
Frullanti E; Berking C; Harbeck N; Jézéquel P; Haugen A; Mawrin C; Parise O; Sasaki H; Tsuchiya N; Dragani TA
Eur J Cancer Prev; 2011 Jul; 20(4):340-7. PubMed ID: 21412156
[TBL] [Abstract][Full Text] [Related]
8. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
[TBL] [Abstract][Full Text] [Related]
10. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
[TBL] [Abstract][Full Text] [Related]
11. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
12. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
[TBL] [Abstract][Full Text] [Related]
13. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 4 Gly388 Arg polymorphism is not associated with pre-eclampsia in Turkish women.
Gunes EG; Pinarbasi E
J Obstet Gynaecol Res; 2011 Dec; 37(12):1824-7. PubMed ID: 21827571
[TBL] [Abstract][Full Text] [Related]
15. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
[TBL] [Abstract][Full Text] [Related]
16. FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
Ho CK; Anwar S; Nanda J; Habib FK
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):94-6. PubMed ID: 19918264
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas.
Wimmer E; Ihrler S; Gires O; Streit S; Issing W; Bergmann C
World J Clin Oncol; 2019 Mar; 10(3):136-148. PubMed ID: 30949443
[TBL] [Abstract][Full Text] [Related]
18. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
[TBL] [Abstract][Full Text] [Related]
19.
Akdeniz Odemis D; Tuncer SB; Adamnejad Ghafour A; Jabbarli K; Gider Y; Celik B; Kuru Turkcan G; Sukruoglu Erdogan O; Kilic Erciyas S; Avsar M; Kebudi R; Buyukkapu Bay S; Tuncer S; Yazici H
J Oncol; 2020; 2020():9401038. PubMed ID: 33456465
[TBL] [Abstract][Full Text] [Related]
20. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
